{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:47:13Z","timestamp":1777513633847,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":398,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CBB APQ 02149\/12"],"award-info":[{"award-number":["CBB APQ 02149\/12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.exppara.2021.108123","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T22:35:08Z","timestamp":1623796508000},"page":"108123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route"],"prefix":"10.1016","volume":"226-227","author":[{"given":"Vanessa Silva","family":"Gontijo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Ant\u00f4nio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Ferreira Espuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poliany Graziella de","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2628-0357","authenticated-orcid":false,"given":"Juliana Barbosa","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0223-8982","authenticated-orcid":false,"given":"Levy Bueno","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Paranho","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemeire Brondi","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossimiriam Pereira","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Jos\u00e9","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2021.108123_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2018.09.006","article-title":"Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis","author":"Alc\u00e2ntara","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.exppara.2021.108123_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21186839","article-title":"1,4-disubstituted-1,2,3-triazole compounds induce ultrastructural alterations in leishmania amazonensis promastigote: an in vitro antileishmanial and in silico pharmacokinetic study","volume":"21","author":"Almeida-Souza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exppara.2021.108123_bib3","doi-asserted-by":"crossref","DOI":"10.1590\/1806-9282.64.03.281","article-title":"Human leishmaniasis in Brazil: a general review","author":"Anversa","year":"2018","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.exppara.2021.108123_bib4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in Leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib5","series-title":"Qu\u00edmica medicinal: as bases moleculares da a\u00e7\u00e3o dos f\u00e1rmacos","author":"Barreiro","year":"2001"},{"key":"10.1016\/j.exppara.2021.108123_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exppara.2021.108123_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2018.10.016","article-title":"New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates","author":"Bhattacharya","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.exppara.2021.108123_bib8","doi-asserted-by":"crossref","first-page":"111676","DOI":"10.1016\/j.ejmech.2019.111676","article-title":"Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics","volume":"183","author":"Borsari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib9","doi-asserted-by":"crossref","DOI":"10.1023\/B:PHAM.0000026420.79421.8f","article-title":"The complexities of hepatic drug transport: current knowledge and emerging concepts","author":"Chandra","year":"2004","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.exppara.2021.108123_bib10","series-title":"Dosage Form Design Parameters","first-page":"731","article-title":"Computer-aided prediction of pharmacokinetic (ADMET) properties","author":"Chandrasekaran","year":"2018"},{"key":"10.1016\/j.exppara.2021.108123_bib11","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182017000993","article-title":"Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art","author":"Charlton","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2021.108123_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exppara.2017.03.005","article-title":"An in silico functional annotation and screening of potential drug targets derived from Leishmania spp. hypothetical proteins identified by immunoproteomics","volume":"176","author":"Ch\u00e1vez-Fumagalli","year":"2017","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2021.108123_bib13","first-page":"890","article-title":"In vivo evaluation of leishmanicidal activity of benzophenone derivatives by qPCR","author":"Colombo","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00436-010-2247-6","article-title":"Detection of Leishmania (Leishmania) infantum RNA in fleas and ticks collected from naturally infected dogs","volume":"109","author":"Colombo","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2021.108123_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exppara.2015.08.014","article-title":"Performance of a real time PCR for leishmaniasis diagnosis using a L. (L.) infantum hypothetical protein as target in canine samples","volume":"157","author":"Colombo","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2021.108123_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2021.108123_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.trstmh.2006.03.009","article-title":"Miltefosine - discovery of the antileishmanial activity of phospholipid derivatives","volume":"100","author":"Croft","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2021.108123_bib18","doi-asserted-by":"crossref","first-page":"105539","DOI":"10.1016\/j.actatropica.2020.105539","article-title":"LEISHMANICIDAL ACTIVITY in vivo OF A MILTEFOSINE DERIVATIVE IN Mesocricetus auratus","volume":"209","author":"da Silva","year":"2020","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2021.108123_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpara.2020.01.001","article-title":"Vaccination against canine leishmaniasis in Brazil","volume":"50","author":"Dantas-Torres","year":"2020","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2021.108123_bib20","article-title":"ChEBI: a database and ontology for chemical entities of biological interest","volume":"36","author":"Degtyarenko","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exppara.2021.108123_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0707306","article-title":"In silico pharmacology for drug discovery: applications to targets and beyond","author":"Ekins","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exppara.2021.108123_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2019.06.051","article-title":"Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents","volume":"179","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ejmech.2007.02.020","article-title":"Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents","volume":"42","author":"Ferreira","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib24","doi-asserted-by":"crossref","first-page":"20930","DOI":"10.1074\/jbc.M111.228213","article-title":"The Leishmania donovani UMP synthase is essential for promastigote viability and has an unusual tetrameric structure that exhibits substrate-controlled oligomerization","volume":"286","author":"French","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib25","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.1202593109","article-title":"Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation","volume":"109","author":"Fyfe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exppara.2021.108123_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2958.2011.07799.x","article-title":"The Leishmania nicotinamidase is essential for NAD + production and parasite proliferation","volume":"82","author":"Gazanion","year":"2011","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.exppara.2021.108123_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejmech.2015.06.005","article-title":"Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines","volume":"101","author":"Gontijo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00044-014-1137-3","article-title":"Long-chain alkyltriazoles as antitumor agents: synthesis, physicochemical properties, and biological and computational evaluation","volume":"24","author":"Gontijo","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.exppara.2021.108123_bib29","doi-asserted-by":"crossref","first-page":"26838","DOI":"10.1074\/jbc.M111.237099","article-title":"Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14\u03b1-demethylase (CYP51) from Leishmania infantum","volume":"286","author":"Hargrove","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bioorg.2018.11.040","article-title":"Antiproliferative 3-deoxysphingomyelin analogs: design, synthesis, biological evaluation and molecular docking of pyrrolidine-based 3-deoxysphingomyelin analogs as anticancer agents","volume":"84","author":"Hassan","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104437","article-title":"Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: in silico ADMET, in vitro activity, docking and molecular dynamic simulations","volume":"105","author":"Holanda","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib32","first-page":"142","article-title":"Concept of drug likeness in pharmaceutical research","volume":"6","author":"Jadhav","year":"2015","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.exppara.2021.108123_bib33","series-title":"In Silico Drug Design","first-page":"161","article-title":"Molecular docking: a structure-based approach for drug repurposing","author":"Kumar","year":"2019"},{"key":"10.1016\/j.exppara.2021.108123_bib34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in leishmania donovani promastigotes","volume":"51","author":"Luque-Ortega","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108123_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00278-4","article-title":"Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania","volume":"111","author":"Lux","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2021.108123_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2014.03.001","article-title":"Structures of the Leishmania infantum polymerase beta","volume":"18","author":"Mejia","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.exppara.2021.108123_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2011.05.012","article-title":"Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human","author":"Michel","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2021.108123_bib38","doi-asserted-by":"crossref","DOI":"10.4103\/ijpvm.IJPVM_116_18","article-title":"Leishmania vaccines entered in clinical trials: a review of literature","author":"Moafi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.exppara.2021.108123_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1107\/S2053230X14007845","article-title":"Structure of tyrosine aminotransferase from Leishmania infantum","volume":"70","author":"Moreno","year":"2014","journal-title":"Acta Crystallogr. Sect. FStructural Biol. Commun."},{"key":"10.1016\/j.exppara.2021.108123_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijpddr.2014.06.001","article-title":"Tyrosine aminotransferase from Leishmania infantum: a new drug target candidate","volume":"4","author":"Moreno","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.exppara.2021.108123_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/138920021609151201113537","article-title":"Interaction of drug or food with drug transporters in intestine and liver","volume":"16","author":"Nakanishi","year":"2015","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.exppara.2021.108123_bib42","doi-asserted-by":"crossref","first-page":"38328","DOI":"10.1039\/D0RA07881F","article-title":"Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues","volume":"10","author":"Nandikolla","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.exppara.2021.108123_bib43","series-title":"Guide for the Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals","author":"National Research Council Committee","year":"2011"},{"key":"10.1016\/j.exppara.2021.108123_bib44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.yrtph.2015.09.008","article-title":"Effect of exposure routes on the relationships of lethal toxicity to rats from oral, intravenous, intraperitoneal and intramuscular routes","volume":"73","author":"Ning","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.exppara.2021.108123_bib45","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.3390\/molecules18077761","article-title":"In-silico Leishmania target selectivity of antiparasitic terpenoids","volume":"18","author":"Ogungbe","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.exppara.2021.108123_bib46","article-title":"Exploring sand fly salivary proteins to design multi-epitope subunit vaccine to fight against visceral leishmaniasis","author":"Pandey","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.exppara.2021.108123_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104122","article-title":"Synthesis, trypanocidal and anti-leishmania activity of new triazole-lapachol and nor-lapachol hybrids","volume":"103","author":"Pertino","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.exppara.2021.108123_bib48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.actatropica.2014.05.017","article-title":"Histamine H1-receptor antagonists against Leishmania (L.) infantum: an in vitro and in vivo evaluation using phosphatidylserine-liposomes","volume":"137","author":"Pinto","year":"2014","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2021.108123_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","article-title":"Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi","volume":"130","author":"Reim\u00e3o","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2021.108123_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exppara.2011.02.021","article-title":"In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR","volume":"128","author":"Reim\u00e3o","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2021.108123_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JCM.02029-06","article-title":"Molecular diagnosis of leishmaniasis: current status and future applications","volume":"45","author":"Reithinger","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.exppara.2021.108123_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193602","article-title":"The crystal structure of the Leishmania infantum Silent Information Regulator 2 related protein 1: implications to protein function and drug design","volume":"13","author":"Ronin","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.exppara.2021.108123_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69512-y","article-title":"Mapping N- and C-terminals of Leishmania donovani tyrosine aminotransferase by gene truncation strategy: a functional study using in vitro and in silico approaches","volume":"10","author":"Sasidharan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exppara.2021.108123_bib54","series-title":"Protein Preparation Wizard","author":"Schr\u00f6dinger Release 2019-1","year":"2019"},{"key":"10.1016\/j.exppara.2021.108123_bib55","first-page":"91","article-title":"The modulatory role of phospholipids, phosphorylcholine ethers and alkylphosphocholines in signal transduction","volume":"130","author":"Sharikadze","year":"2006","journal-title":"Georgian Med. News"},{"key":"10.1016\/j.exppara.2021.108123_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/bi700989m","article-title":"Catalysis and structural properties of Leishmania infantum glyoxalase II: trypanothione specificity and phylogeny","volume":"47","author":"Silva","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.exppara.2021.108123_bib57","first-page":"269","article-title":"An eight-day method for screening compounds against leishmania donovani in the golden hamster","volume":"5","author":"Stauber","year":"1958","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.exppara.2021.108123_bib58","doi-asserted-by":"crossref","DOI":"10.1017\/S0033583515000190","article-title":"In silico ADME\/T modelling for rational drug design","author":"Wang","year":"2015","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.exppara.2021.108123_bib59","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s11030-018-9866-8","article-title":"ADME properties evaluation in drug discovery: in silico prediction of blood\u2013brain partitioning","volume":"22","author":"Zhu","year":"2018","journal-title":"Mol. Divers."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489421000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489421000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:49:17Z","timestamp":1777391357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489421000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":59,"alternative-id":["S0014489421000606"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2021.108123","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2021.108123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108123"}}